Oct 03, 2011, 03.56 PM IST
Vivimed Labs has acquired entire equity stake in Kolkata-based privately held pharma company Klar Sehen to boost its domestic presence specialty medicine areas.
Vivimed Labs has acquired entire equity stake in Kolkata-based privately held pharma company Klar Sehen to boost its domestic presence in specialty medicine areas.
The financial terms of the deal were not disclosed.
The 30-year-old company operates in a niche ophthalmic segment and owns about 50 trademarks and brands like Renicol, Dexacort, Lysicon-V, in eye care, Vivimed said Monday.
Klar Sehen has strong marketing presence in North East, Bihar and Andhra Pradesh, it said. It has manufacturing facilities at Kolkata and Hyderabad and also has arrangements to manufacture some of its products in Uttarakhand, and operates with over 150 medical sales professionals, Vivimed said.
Earlier last month Vivimed had completed the acquisition of Octtantis Nobel, a Hyderabad-based pharmaceutical marketing company.
Vivimed Labs shares were trading up 1.2% at Rs 247.50 on NSE on Monday.
Vivimed Labs stock price
On December 05, 2013, at 12:51 hrs Vivimed Labs was quoting at Rs 177.00, down Rs 1.3, or 0.73 percent. The 52-week high of the share was Rs 361.00 and the 52-week low was Rs 96.00.
The company's trailing 12-month (TTM) EPS was at Rs 21.19 per share as per the quarter ended September 2013. The stock's price-to-earnings (P/E) ratio was 8.35. The latest book value of the company is Rs 212.43 per share. At current value, the price-to-book value of the company is 0.83.
Action in Vivimed Labs
Video of the day
Dec 5 2013, 12:20
- in FII View
Dec 4 2013, 11:08
- in FII View
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.